25 XP   0   0   10

BioLargo Inc
Buy, Hold or Sell?

Let's analyse Biolargo together

PenkeI guess you are interested in BioLargo Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioLargo Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioLargo Inc

I send you an email if I find something interesting about BioLargo Inc.

Quick analysis of Biolargo (30 sec.)










What can you expect buying and holding a share of Biolargo? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$0.02
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$0.01
Return On Investment
1.7%

For what price can you sell your share?

Current Price per Share
$0.35
Expected price per share
$0.31 - $0.45
How sure are you?
50%

1. Valuation of Biolargo (5 min.)




Live pricePrice per Share (EOD)

$0.35

Intrinsic Value Per Share

$-0.06 - $-0.06

Total Value Per Share

$-0.04 - $-0.05

2. Growth of Biolargo (5 min.)




Is Biolargo growing?

Current yearPrevious yearGrowGrow %
How rich?$3.8m$1.4m$1.9m57.4%

How much money is Biolargo making?

Current yearPrevious yearGrowGrow %
Making money-$891.5k-$1.4m$586k65.7%
Net Profit Margin-43.7%-154.5%--

How much money comes from the company's main activities?

3. Financial Health of Biolargo (5 min.)




4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  


Richest
#312 / 319

Most Revenue
#308 / 319

Most Profit
#236 / 319

Most Efficient
#305 / 319

What can you expect buying and holding a share of Biolargo? (5 min.)

Welcome investor! Biolargo's management wants to use your money to grow the business. In return you get a share of Biolargo.

What can you expect buying and holding a share of Biolargo?

First you should know what it really means to hold a share of Biolargo. And how you can make/lose money.

Speculation

The Price per Share of Biolargo is $0.3549. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biolargo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biolargo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biolargo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1.2%0.00-0.9%-0.01-1.4%-0.01-1.7%0.00-1.3%
Usd Book Value Change Per Share0.00-0.3%0.000.4%0.000.3%0.000.2%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.3%0.000.4%0.000.3%0.000.2%0.000.1%
Usd Price Per Share0.17-0.19-0.22-0.20-0.33-
Price to Earnings Ratio-10.25--22.82--16.37--11.99--8.82-
Price-to-Total Gains Ratio-160.83--633.06--1,236.81--433.59--579.32-
Price to Book Ratio12.89-17.30-47.18-4.65--267.41-
Price-to-Total Gains Ratio-160.83--633.06--1,236.81--433.59--579.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3549
Number of shares2817
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (2817 shares)4.342.33
Gains per Year (2817 shares)17.369.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1017709-1
2035240198
30524102817
40695803726
50877504735
601049205644
7012210906553
8013912607562
9015614308471
10017416009380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.028.012.00.0%1.028.066.01.1%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%15.025.00.037.5%32.063.00.033.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.095.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%15.025.00.037.5%32.063.00.033.7%

Fundamentals of Biolargo

About BioLargo Inc

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. The company was incorporated in 1991 and is based in Westminster, California.

Fundamental data was last updated by Penke on 2024-03-29 03:37:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BioLargo Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biolargo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Net Profit Margin of -44.9% means that $-0.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioLargo Inc:

  • The MRQ is -44.9%. The company is making a huge loss. -2
  • The TTM is -43.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-44.9%TTM-43.7%-1.2%
TTM-43.7%YOY-154.5%+110.9%
TTM-43.7%5Y-297.1%+253.4%
5Y-297.1%10Y-530.0%+232.9%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-44.9%3.1%-48.0%
TTM-43.7%3.6%-47.3%
YOY-154.5%6.4%-160.9%
5Y-297.1%5.2%-302.3%
10Y-530.0%5.6%-535.6%
1.1.2. Return on Assets

Shows how efficient Biolargo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • -18.3% Return on Assets means that Biolargo generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioLargo Inc:

  • The MRQ is -18.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-15.0%-3.4%
TTM-15.0%YOY-45.4%+30.4%
TTM-15.0%5Y-42.6%+27.6%
5Y-42.6%10Y-60.0%+17.4%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.3%0.6%-18.9%
TTM-15.0%0.8%-15.8%
YOY-45.4%1.5%-46.9%
5Y-42.6%1.1%-43.7%
10Y-60.0%1.2%-61.2%
1.1.3. Return on Equity

Shows how efficient Biolargo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • -17.0% Return on Equity means Biolargo generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioLargo Inc:

  • The MRQ is -17.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.0%TTM-14.3%-2.7%
TTM-14.3%YOY-32.2%+17.9%
TTM-14.3%5Y-22.9%+8.6%
5Y-22.9%10Y-11.5%-11.5%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.0%1.1%-18.1%
TTM-14.3%1.3%-15.6%
YOY-32.2%2.9%-35.1%
5Y-22.9%2.1%-25.0%
10Y-11.5%2.2%-13.7%

1.2. Operating Efficiency of BioLargo Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biolargo is operating .

  • Measures how much profit Biolargo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioLargo Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-31.4%+31.4%
TTM-31.4%YOY-128.6%+97.2%
TTM-31.4%5Y-241.1%+209.7%
5Y-241.1%10Y-342.6%+101.5%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.0%-6.0%
TTM-31.4%3.0%-34.4%
YOY-128.6%8.8%-137.4%
5Y-241.1%7.3%-248.4%
10Y-342.6%5.9%-348.5%
1.2.2. Operating Ratio

Measures how efficient Biolargo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 2.02 means that the operating costs are $2.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioLargo Inc:

  • The MRQ is 2.023. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.585. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.023TTM1.585+0.438
TTM1.585YOY2.798-1.213
TTM1.5855Y3.755-2.170
5Y3.75510Y3.504+0.250
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0231.721+0.302
TTM1.5851.699-0.114
YOY2.7981.583+1.215
5Y3.7551.633+2.122
10Y3.5041.314+2.190

1.3. Liquidity of BioLargo Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biolargo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 2.70 means the company has $2.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioLargo Inc:

  • The MRQ is 2.696. The company is able to pay all its short-term debts. +1
  • The TTM is 2.788. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.696TTM2.788-0.092
TTM2.788YOY1.808+0.979
TTM2.7885Y1.193+1.594
5Y1.19310Y0.749+0.444
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6961.606+1.090
TTM2.7881.617+1.171
YOY1.8081.682+0.126
5Y1.1931.774-0.581
10Y0.7491.346-0.597
1.3.2. Quick Ratio

Measures if Biolargo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Quick Ratio of 0.84 means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioLargo Inc:

  • The MRQ is 0.835. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.952. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.835TTM1.952-1.117
TTM1.952YOY0.569+1.383
TTM1.9525Y0.562+1.390
5Y0.56210Y0.291+0.271
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8350.601+0.234
TTM1.9520.634+1.318
YOY0.5690.779-0.210
5Y0.5620.738-0.176
10Y0.2910.746-0.455

1.4. Solvency of BioLargo Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biolargo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biolargo to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.42 means that Biolargo assets are financed with 41.7% credit (debt) and the remaining percentage (100% - 41.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioLargo Inc:

  • The MRQ is 0.417. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.463. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.463-0.046
TTM0.463YOY0.597-0.135
TTM0.4635Y0.946-0.483
5Y0.94610Y1.563-0.617
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4170.419-0.002
TTM0.4630.420+0.043
YOY0.5970.425+0.172
5Y0.9460.405+0.541
10Y1.5630.420+1.143
1.4.2. Debt to Equity Ratio

Measures if Biolargo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Debt to Equity ratio of 38.6% means that company has $0.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioLargo Inc:

  • The MRQ is 0.386. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.450. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.386TTM0.450-0.064
TTM0.450YOY0.446+0.004
TTM0.4505Y0.554-0.104
5Y0.55410Y1.534-0.980
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3860.799-0.413
TTM0.4500.749-0.299
YOY0.4460.743-0.297
5Y0.5540.761-0.207
10Y1.5340.817+0.717

2. Market Valuation of BioLargo Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biolargo generates.

  • Above 15 is considered overpriced but always compare Biolargo to the Chemicals industry mean.
  • A PE ratio of -10.25 means the investor is paying $-10.25 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioLargo Inc:

  • The EOD is -21.405. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.253. Based on the earnings, the company is expensive. -2
  • The TTM is -22.823. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.405MRQ-10.253-11.152
MRQ-10.253TTM-22.823+12.570
TTM-22.823YOY-16.369-6.455
TTM-22.8235Y-11.987-10.837
5Y-11.98710Y-8.825-3.162
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-21.4059.098-30.503
MRQ-10.2539.548-19.801
TTM-22.82313.416-36.239
YOY-16.36912.214-28.583
5Y-11.98714.106-26.093
10Y-8.82522.461-31.286
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioLargo Inc:

  • The EOD is -24.674. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.819. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -96.893. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.674MRQ-11.819-12.855
MRQ-11.819TTM-96.893+85.074
TTM-96.893YOY-16.379-80.514
TTM-96.8935Y-31.064-65.829
5Y-31.06410Y-21.844-9.221
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-24.6742.038-26.712
MRQ-11.8192.400-14.219
TTM-96.8931.188-98.081
YOY-16.3790.443-16.822
5Y-31.0641.741-32.805
10Y-21.8442.252-24.096
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biolargo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 12.89 means the investor is paying $12.89 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioLargo Inc:

  • The EOD is 26.917. Based on the equity, the company is expensive. -2
  • The MRQ is 12.894. Based on the equity, the company is expensive. -2
  • The TTM is 17.296. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.917MRQ12.894+14.024
MRQ12.894TTM17.296-4.403
TTM17.296YOY47.178-29.882
TTM17.2965Y4.654+12.642
5Y4.65410Y-267.412+272.066
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD26.9171.292+25.625
MRQ12.8941.433+11.461
TTM17.2961.495+15.801
YOY47.1781.902+45.276
5Y4.6541.750+2.904
10Y-267.4122.064-269.476
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioLargo Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0010.002-169%0.001-219%0.001-228%0.000-393%
Book Value Per Share--0.0130.012+13%0.005+165%0.002+645%-0.001+106%
Current Ratio--2.6962.788-3%1.808+49%1.193+126%0.749+260%
Debt To Asset Ratio--0.4170.463-10%0.597-30%0.946-56%1.563-73%
Debt To Equity Ratio--0.3860.450-14%0.446-14%0.554-30%1.534-75%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.003-20%-0.005+23%-0.006+48%-0.005+14%
Free Cash Flow Per Share---0.004-0.002-34%-0.003-5%-0.003-8%-0.003-5%
Free Cash Flow To Equity Per Share---0.0020.002-181%0.000-972%0.001-398%0.001-274%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max---0.063--------
Intrinsic Value_10Y_min---0.057--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.030--------
Intrinsic Value_3Y_min---0.029--------
Intrinsic Value_5Y_max---0.045--------
Intrinsic Value_5Y_min---0.042--------
Market Cap102743550.000+52%49215000.00053557500.000-8%64413750.000-24%57593130.000-15%94221393.750-48%
Net Profit Margin---0.449-0.437-3%-1.545+244%-2.971+562%-5.300+1080%
Operating Margin----0.3140%-1.2860%-2.4110%-3.4260%
Operating Ratio--2.0231.585+28%2.798-28%3.755-46%3.504-42%
Pb Ratio26.917+52%12.89417.296-25%47.178-73%4.654+177%-267.412+2174%
Pe Ratio-21.405-109%-10.253-22.823+123%-16.369+60%-11.987+17%-8.825-14%
Price Per Share0.355+52%0.1700.185-8%0.223-24%0.199-15%0.325-48%
Price To Free Cash Flow Ratio-24.674-109%-11.819-96.893+720%-16.379+39%-31.064+163%-21.844+85%
Price To Total Gains Ratio-335.763-109%-160.833-633.057+294%-1236.808+669%-433.587+170%-579.317+260%
Quick Ratio--0.8351.952-57%0.569+47%0.562+48%0.291+187%
Return On Assets---0.183-0.150-18%-0.454+148%-0.426+132%-0.600+227%
Return On Equity---0.170-0.143-16%-0.322+90%-0.229+35%-0.115-32%
Total Gains Per Share---0.0010.002-169%0.001-219%0.001-228%0.000-393%
Usd Book Value--3817000.0003375750.000+13%1438500.000+165%512200.000+645%-222715.275+106%
Usd Book Value Change Per Share---0.0010.002-169%0.001-219%0.001-228%0.000-393%
Usd Book Value Per Share--0.0130.012+13%0.005+165%0.002+645%-0.001+106%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.003-20%-0.005+23%-0.006+48%-0.005+14%
Usd Free Cash Flow---1041000.000-690250.000-34%-988750.000-5%-960102.800-8%-690495.400-34%
Usd Free Cash Flow Per Share---0.004-0.002-34%-0.003-5%-0.003-8%-0.003-5%
Usd Free Cash Flow To Equity Per Share---0.0020.002-181%0.000-972%0.001-398%0.001-274%
Usd Market Cap102743550.000+52%49215000.00053557500.000-8%64413750.000-24%57593130.000-15%94221393.750-48%
Usd Price Per Share0.355+52%0.1700.185-8%0.223-24%0.199-15%0.325-48%
Usd Profit---1200000.000-891500.000-26%-1477500.000+23%-1764040.450+47%-1360017.550+13%
Usd Revenue--2672000.0002489500.000+7%1144000.000+134%1053610.350+154%574775.000+365%
Usd Total Gains Per Share---0.0010.002-169%0.001-219%0.001-228%0.000-393%
 EOD+5 -3MRQTTM+9 -23YOY+18 -145Y+17 -1510Y+18 -15

3.2. Fundamental Score

Let's check the fundamental score of BioLargo Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.405
Price to Book Ratio (EOD)Between0-126.917
Net Profit Margin (MRQ)Greater than0-0.449
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.835
Current Ratio (MRQ)Greater than12.696
Debt to Asset Ratio (MRQ)Less than10.417
Debt to Equity Ratio (MRQ)Less than10.386
Return on Equity (MRQ)Greater than0.15-0.170
Return on Assets (MRQ)Greater than0.05-0.183
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of BioLargo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.526
Ma 20Greater thanMa 500.351
Ma 50Greater thanMa 1000.294
Ma 100Greater thanMa 2000.231
OpenGreater thanClose0.338
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,545
Total Liabilities2,728
Total Stockholder Equity7,069
 As reported
Total Liabilities 2,728
Total Stockholder Equity+ 7,069
Total Assets = 6,545

Assets

Total Assets6,545
Total Current Assets4,691
Long-term Assets1,854
Total Current Assets
Cash And Cash Equivalents 3,042
Net Receivables 1,453
Inventory 122
Other Current Assets 74
Total Current Assets  (as reported)4,691
Total Current Assets  (calculated)4,691
+/-0
Long-term Assets
Property Plant Equipment 1,376
Long Term Investments 15
Intangible Assets 34
Long-term Assets  (as reported)1,854
Long-term Assets  (calculated)1,425
+/- 429

Liabilities & Shareholders' Equity

Total Current Liabilities1,740
Long-term Liabilities988
Total Stockholder Equity7,069
Total Current Liabilities
Short Long Term Debt 300
Accounts payable 828
Total Current Liabilities  (as reported)1,740
Total Current Liabilities  (calculated)1,128
+/- 612
Long-term Liabilities
Long term Debt 293
Capital Lease Obligations Min Short Term Debt792
Long-term Liabilities  (as reported)988
Long-term Liabilities  (calculated)1,085
+/- 97
Total Stockholder Equity
Total Stockholder Equity (as reported)7,069
Total Stockholder Equity (calculated)0
+/- 7,069
Other
Capital Stock193
Common Stock Shares Outstanding 288,627
Net Invested Capital 7,662
Net Working Capital 2,951
Property Plant and Equipment Gross 1,376



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
7,616
7,231
6,836
10,248
9,701
9,267
8,139
4,590
4,150
4,105
7,797
4,374
4,191
4,108
1,854
1
0
0
0
0
0
181
145
283
711
390
120
246
153
11,633
11,454
11,458
11,317
11,077
10,552
10,009
9,865
9,479
9,236
181
176
93
291
460
682
325
301
246
448
638
543
269
201
174
138
167
485
426
297
261
383
264
768
1,910
1,190
1,023
1,968
2,113
1,498
643
1,741
1,495
1,455
1,168
1,089
3,185
3,395
3,583
5,104
3,621
3,556
4,896
5,188
4,942
5,337
5,445
5,284
3,023
3,289
3,377
4,371
4,858
6,647
6,680
6,545
6,5456,6806,6474,8584,3713,3773,2893,0235,2845,4455,3374,9425,1884,8963,5563,6215,1043,5833,3953,1851,0891,1681,4551,4951,7416431,4982,1131,9681,0231,1901,910768264383261297426485167138174201269543638448246301325682460291931761819,2369,4799,86510,00910,55211,07711,31711,45811,45411,6331532461203907112831451810000011,8544,1084,1914,3747,7974,1054,1504,5908,1399,2679,70110,2486,8367,2317,616
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,017
1,410
561
1,447
1,158
1,114
823
752
955
782
1,001
2,566
1,065
1,080
1,678
1,873
1,505
1,922
2,052
1,911
1,801
2,048
2,141
2,532
3,153
4,874
4,847
4,691
4,6914,8474,8743,1532,5322,1412,0481,8011,9112,0521,9221,5051,8731,6781,0801,0652,5661,0017829557528231,1141,1581,4475611,4102,0170000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146
84
126
457
593
614
367
90
217
66
139
134
109
55
247
425
640
244
191
129
311
515
428
151
91
67
53
92
363
318
151
154
227
97
560
1,763
1,022
889
1,732
1,911
1,176
433
1,252
990
922
651
534
655
512
706
2,136
655
744
1,207
1,117
716
1,341
1,357
1,098
962
974
1,226
1,268
1,851
3,291
3,596
3,042
3,0423,5963,2911,8511,2681,2269749621,0981,3571,3417161,1171,2077446552,1367065126555346519229901,2524331,1761,9111,7328891,0221,7635609722715415131836392536791151428515311129191244640425247551091341396621790367614593457126841460000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
62
78
114
94
102
90
112
257
210
232
306
355
259
258
413
484
277
343
464
513
690
578
884
1,064
1,504
1,106
1,453
1,4531,1061,5041,06488457869051346434327748441325825935530623221025711290102941147862680000000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
192
105
173
137
142
99
132
157
107
53
28
0
0
0
0
0
0
0
0
0
0
0
0
0
64
43
21
17
7
0
0
5
5
5
4
5
13
5
5
6
39
4
4
4
4
1
1
1
0
0
0
0
0
4
4
0
45
45
45
45
45
45
56
49
93
44
32
4
147
13
42
20
33
2,000
33,412
0
0
0
0
0
0
0
0
0
0
0
0
0
114
81
120
118
1,326
1,309
74
741,3091,32611812081114000000000000033,4122,0003320421314743244934956454545454545044000001114444396551354555007172143640000000000000285310715713299142137173105192
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,613
2,582
2,538
2,556
2,476
3,218
3,315
3,437
3,415
3,393
3,373
1,222
1,241
1,236
1,839
1,705
391
542
1,854
1,8545423911,7051,8391,2361,2411,2223,3733,3933,4153,4373,3153,2182,4762,5562,5382,5822,6130000000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
4,328
4,287
4,164
3,709
3,277
3,187
3,151
2,360
2,289
2,578
6,989
29
27
25
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
15
26
24
21
19
17
14
12
9
7
8
5
4
3
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
55
59
54
51
55
109
117
122
125
126
509
478
447
506
449
417
398
401
389
380
360
514
511
543
1,092
1,154
1,228
1,349
1,376
1,3761,3491,2281,1541,0925435115143603803894013984174495064474785091261251221171095551545955500000000000000111345879121417192124261516000000000000000000222527296,9892,5782,2892,3603,1513,1873,2773,7094,1644,2874,328
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99
85
73
63
53
40
40
48
40
33
33
33
27
21
15
15212733333340484040536373859900000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
4,344
4,128
3,910
1,827
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,549
11,273
10,996
10,719
10,442
10,166
9,888
9,611
9,334
9,057
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
27
25
22
19
16
14
40
10
34
31
34
0
0
0
0
0
1,893
1,893
1,893
1,893
1,893
1,893
2,021
2,150
2,150
2,150
2,150
0
0
0
34
34
34
34
34
34343434340002,1502,1502,1502,1502,0211,8931,8931,8931,8931,8931,89300000343134104014161922252730000000000000000000009,0579,3349,6119,88810,16610,44210,71910,99611,27311,549000000000000001,8273,9104,1284,34400000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
35
35
35
35
823
823
35
35
35
35
69
99
69
0
0
0
0
0
000006999693535353582382335353535350000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
168
175
172
3,626
3,591
3,991
4,175
3,385
1,080
985
2,044
2,401
1,869
2,352
2,480
2,925
2,991
3,321
3,464
3,708
3,952
4,361
4,636
5,074
5,943
5,714
5,864
5,575
2,979
1,402
1,942
2,422
3,052
2,899
2,574
2,655
3,751
3,344
4,088
4,044
5,159
3,477
3,444
3,053
2,365
2,309
2,600
1,764
2,194
1,576
1,594
558
682
748
501
732
509
481
623
653
797
749
511
769
972
1,451
2,128
2,883
3,120
4,119
4,142
4,905
6,070
1,812
2,070
4,308
5,188
5,502
6,114
5,801
6,192
6,500
4,708
5,177
4,565
4,213
4,281
2,090
1,889
1,989
2,338
2,847
3,095
2,557
2,728
2,7282,5573,0952,8472,3381,9891,8892,0904,2814,2134,5655,1774,7086,5006,1925,8016,1145,5025,1884,3082,0701,8126,0704,9054,1424,1193,1202,8832,1281,4519727695117497976536234815097325017486825581,5941,5762,1941,7642,6002,3092,3653,0533,4443,4775,1594,0444,0883,3443,7512,6552,5742,8993,0522,4221,9421,4022,9795,5755,8645,7145,9435,0744,6364,3613,9523,7083,4643,3212,9912,9252,4802,3521,8692,4012,0449851,0803,3854,1753,9913,5913,626172175168
   > Total Current Liabilities 
168
175
172
3,626
3,591
3,991
4,175
3,385
1,080
985
2,044
2,401
1,869
2,352
2,480
2,925
2,991
3,321
3,464
3,708
3,952
4,361
4,636
5,074
5,943
5,714
5,864
5,347
2,461
1,006
1,807
1,496
2,716
2,600
2,144
2,082
3,250
3,143
3,581
3,465
4,383
2,613
2,356
2,389
1,603
2,087
2,298
1,374
1,817
1,576
1,594
558
682
748
501
732
509
481
623
653
791
710
401
460
357
411
831
1,155
697
3,737
3,612
4,216
5,053
943
1,828
2,491
3,125
4,474
4,757
4,354
4,731
4,776
3,189
3,544
2,973
2,432
2,515
1,374
1,244
1,179
1,029
1,576
1,799
1,294
1,740
1,7401,2941,7991,5761,0291,1791,2441,3742,5152,4322,9733,5443,1894,7764,7314,3544,7574,4743,1252,4911,8289435,0534,2163,6123,7376971,1558314113574604017107916536234815097325017486825581,5941,5761,8171,3742,2982,0871,6032,3892,3562,6134,3833,4653,5813,1433,2502,0822,1442,6002,7161,4961,8071,0062,4615,3475,8645,7145,9435,0744,6364,3613,9523,7083,4643,3212,9912,9252,4802,3521,8692,4012,0449851,0803,3854,1753,9913,5913,626172175168
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
875
460
3,154
2,877
3,212
3,772
0
0
0
0
0
4,068
3,592
0
0
0
0
0
0
0
0
0
0
0
0
66
66
0
066660000000000003,5924,068000003,7723,2122,8773,1544608750000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
875
460
3,154
2,877
3,212
3,772
54,643
94
310
2,346
3,654
4,068
3,592
3,796
3,840
2,237
2,333
1,655
1,007
1,007
314
174
81
86
100
66
66
300
300666610086811743141,0071,0071,6552,3332,2373,8403,7963,5924,0683,6542,3463109454,6433,7723,2122,8773,1544608750000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
168
175
172
191
139
524
691
986
780
835
774
1,132
599
922
944
1,256
1,383
1,723
1,866
2,055
2,145
2,221
2,224
2,313
2,404
2,395
2,545
32
1,437
801
809
230
962
305
859
303
392
385
487
479
719
752
621
519
523
458
623
448
479
614
523
334
367
421
393
362
321
314
394
313
312
204
26
64
106
156
53
22
57
159
277
172
274
149
242
302
370
328
297
465
430
394
475
717
685
727
771
499
662
667
536
903
1,224
720
828
8287201,22490353666766249977172768571747539443046529732837030224214927417227715957225315610664262043123133943143213623934213673345236144794486234585235196217527194794873853923038593059622308098011,437322,5452,3952,4042,3132,2242,2212,1452,0551,8661,7231,3831,2569449225991,132774835780986691524139191172175168
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,280
0
159
435
1,187
1,123
1,257
1,023
1,348
1,948
1,166
1,718
1,543
2,079
1,151
849
325
384
286
288
412
649
484
570
124
215
227
8
45
138
117
179
282
354
340
375
396
251
255
577
922
578
807
179
52
77
3,684
66,266
0
116
28
27
35
9
18
72
48
125
220
241
168
91
137
115
201
231
220
0
0220231201115137911682412201254872189352728116066,2663,68477521798075789225772552513963753403542821791171384582272151245704846494122882863843258491,1512,0791,5431,7181,1661,9481,3481,0231,2571,1231,18743515902,280000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,063
1,028
1,357
1,447
1,461
1,724
1,519
1,633
1,592
1,781
1,766
716
645
810
1,309
1,271
1,049
1,020
988
9881,0201,0491,2711,3098106457161,7661,7811,5921,6331,5191,7241,4611,4471,3571,0282,0630000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
643
643
643
643
643
643
643
771
900
900
900
900
0
0
0
0
0
0
0
0
00000000900900900900771643643643643643643643000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
206
195
191
187
176
2,069
2,069
2,069
2,056
2,015
1,893
1,893
2,021
2,150
2,150
2,150
2,150
0
0
0
0
0
0
0
0
000000002,1502,1502,1502,1502,0211,8931,8932,0152,0562,0692,0692,0691761871911952060000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
7,448
7,056
6,664
6,622
6,110
5,276
3,964
1,205
3,070
3,120
5,753
1,973
2,322
1,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,231
9,512
9,036
8,265
8,178
7,978
7,354
6,114
6,135
5,148
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117
0
0
0
0
0
210
352
0
0
0
-1,325
-2,114
-3,754
-3,090
-4,104
-5,203
-1,137
-1,356
-1,496
-2,082
-2,127
-1,120
-2,153
-2,725
2,635
4,677
3,858
4,749
5,063
4,809
4,653
4,485
4,474
4,964
4,878
6,385
7,368
7,069
7,0697,3686,3854,8784,9644,4744,4854,6534,8095,0634,7493,8584,6772,635-2,725-2,153-1,120-2,127-2,082-1,496-1,356-1,137-5,203-4,104-3,090-3,754-2,114-1,32500035221000000117000000000000000005,1486,1356,1147,3547,9788,1788,2659,0369,51210,2310000000000000001,7562,3221,9735,7533,1203,0701,2053,9645,2766,1106,6226,6647,0567,448
   Common Stock
2
2
2
3
3
3
3
3
4
6
11
11
19
21
24
24
24
31
34
34
34
34
41
41
41
41
52
52
58
77
76
77
27
27
28
28
28
29
29
29
29
31
33
35
37
38
38
40
41
44
44
47
48
49
49
50
53
54
55
55
56
56
57
57
58
58
60
62
64
67
68
70
71
86
89
95
97
102
106
111
119
128
148
151
161
168
171
171
176
179
184
186
190
192
0
0192190186184179176171171168161151148128119111106102979589867170686764626058585757565655555453504949484744444140383837353331292929292828282727777677585252414141413434343431242424211911116433333222
   Retained Earnings Total Equity0-145,169-143,84100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150,191
152,507
0
0152,507150,19100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000-127-127-127-127-127-127-127-127-127-127-127-127-125-5-5-5-5-5-5
   Other Stockholders Equity 0-162-155-149-185-126-123-115-110-103-103-101-107-77-99-99-91-98-94-90-67-61-55-62-58-98-93-820000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,958
Cost of Revenue-4,927
Gross Profit5,0315,031
 
Operating Income (+$)
Gross Profit5,031
Operating Expense-14,714
Operating Income-4,756-9,683
 
Operating Expense (+$)
Research Development2,147
Selling General Administrative7,678
Selling And Marketing Expenses-
Operating Expense14,7149,825
 
Net Interest Income (+$)
Interest Income-
Interest Expense-83
Other Finance Cost-0
Net Interest Income-83
 
Pretax Income (+$)
Operating Income-4,756
Net Interest Income-83
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-5,036-4,756
EBIT - interestExpense = -83
-3,864
-3,781
Interest Expense83
Earnings Before Interest and Taxes (EBIT)--4,953
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-5,036
Tax Provision--
Net Income From Continuing Ops-5,036-5,036
Net Income-3,864
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-83
 

Technical Analysis of Biolargo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biolargo. The general trend of Biolargo is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biolargo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioLargo Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.38 < 0.45.

The bearish price targets are: 0.32 > 0.31 > 0.31.

Tweet this
BioLargo Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioLargo Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioLargo Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioLargo Inc. The current macd is 0.01298264.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biolargo price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biolargo. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biolargo price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioLargo Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioLargo Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioLargo Inc. The current adx is 34.82.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biolargo shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
BioLargo Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioLargo Inc. The current sar is 0.36457435.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioLargo Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioLargo Inc. The current rsi is 56.53. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
BioLargo Inc Daily Relative Strength Index (RSI) ChartBioLargo Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioLargo Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biolargo price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioLargo Inc Daily Stochastic Oscillator ChartBioLargo Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioLargo Inc. The current cci is -10.49498747.

BioLargo Inc Daily Commodity Channel Index (CCI) ChartBioLargo Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioLargo Inc. The current cmo is 9.82696743.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioLargo Inc Daily Chande Momentum Oscillator (CMO) ChartBioLargo Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioLargo Inc. The current willr is -35.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biolargo is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioLargo Inc Daily Williams %R ChartBioLargo Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioLargo Inc.

BioLargo Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioLargo Inc. The current atr is 0.0293783.

BioLargo Inc Daily Average True Range (ATR) ChartBioLargo Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioLargo Inc. The current obv is 3,593,571.

BioLargo Inc Daily On-Balance Volume (OBV) ChartBioLargo Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioLargo Inc. The current mfi is 41.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BioLargo Inc Daily Money Flow Index (MFI) ChartBioLargo Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioLargo Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

BioLargo Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioLargo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.526
Ma 20Greater thanMa 500.351
Ma 50Greater thanMa 1000.294
Ma 100Greater thanMa 2000.231
OpenGreater thanClose0.338
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biolargo with someone you think should read this too:
  • Are you bullish or bearish on Biolargo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biolargo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioLargo Inc

I send you an email if I find something interesting about BioLargo Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioLargo Inc.

Receive notifications about BioLargo Inc in your mailbox!